Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement.

Ahmad MasriIslam AbdelkarimMichael S SharbaughAndrew D AlthouseJeffrey XuWei HanStephen Y ChanWilliam E KatzFrederick W CrockMatthew E HarinsteinDustin E KlinerForozan NavidJoon S LeeThomas G GleasonJohn T SchindlerJoão L Cavalcante

Published in: Heart (British Cardiac Society) (2017)

Persistency of even moderate or greater PH at 1 month post-TAVR is common and associated with higher all-cause mortality.

Keyphrases

transcatheter aortic valve replacement
pulmonary hypertension
aortic stenosis
aortic valve
pulmonary artery
high intensity
pulmonary arterial hypertension
type diabetes
heart failure
coronary artery
metabolic syndrome
left ventricular
ejection fraction
skeletal muscle